Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$255.37M
Total Bought:
$51.74M
Total Sold:
$61.31M
Net Transaction:
-$9.57M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Disc Medicine, Inc.(IRON)511,041509,406-1,635$25.11M$32.30M12.65%+$7.18M
Ascendis Pharma A/SADR(ASND)200,285198,977-1,308$29.90M$27.39M10.73%-$2.51M
MoonLake ImmunotherapeuticsCL A(MLTX)298,974346,111+47,137$15.07M$18.74M7.34%+$3.67M
CG Oncology, Inc.(CGON)520,119593,262+73,143$19.62M$17.01M6.66%-$2.61M
Vaxcyte, Inc.(PCVX)204,987204,285-702$23.42M$16.72M6.55%-$6.70M
Cytokinetics, Incorporated(CYTK)331,283348,364+17,081$17.49M$16.39M6.42%-$1.10M
Cargo Therapeutics Inc1,002,4611,007,677+5,216$18.50M$14.53M5.69%-$3.96M
Celcuity Inc.(CELC)946,3351,063,783+117,448$14.11M$13.92M5.45%-$184.9K
Syndax Pharmaceuticals, Inc.(SNDX)501,978988,528+486,550$9.66M$13.07M5.12%+$3.41M
Xenon Pharmaceuticals Inc.(XENE)0322,470+322,470$0$12.64M4.95%+$12.64M
argenx SEADR(ARGX)22,11119,754-2,357$11.99M$12.15M4.76%+$162.8K
Cogent Biosciences, Inc.(COGT)1,712,8991,498,425-214,474$18.50M$11.69M4.58%-$6.81M
Merus N V131,240234,637+103,397$6.56M$9.87M3.86%+$3.31M
Contineum Therapeutics, Inc.CL A(CTNM)77,297573,022+495,725$1.48M$8.39M3.29%+$6.92M
ABIVAX Société AnonymeADS(ABVX)648,019653,071+5,052$7.47M$4.78M1.87%-$2.68M
Kalvista Pharmaceuticals Inc556,489556,4890$6.44M$4.71M1.85%-$1.73M
Inozyme Pharma Inc1,368,8101,374,582+5,772$7.16M$3.81M1.49%-$3.35M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)1,120,409814,533-305,876$4.62M$3.61M1.41%-$1.01M
Amylyx Pharmaceuticals, Inc.(AMLX)0889,073+889,073$0$3.36M1.32%+$3.36M
Crinetics Pharmaceuticals In109,56759,125-50,442$5.60M$3.02M1.18%-$2.58M
Silence Therapeutics plcADS(SLN)481,127395,024-86,103$8.75M$2.72M1.06%-$6.03M
Newamsterdam Pharma Company
ORDINARY SHARES
0100,000+100,000$0$2.57M1.01%+$2.57M
Ocular Therapeutix, Inc.(OCUL)0191,456+191,456$0$1.64M0.64%+$1.64M
MBX Biosciences, Inc.(MBX)018,000+18,000$0$331.7K0.13%+$331.7K
ArriVent BioPharma, Inc.(AVBP)47,2660-47,266$1.11M$0—-$1.11M
BioMarin Pharmaceutical Inc.(BMRN)37,4320-37,432$2.63M$0—-$2.63M
Iteos Therapeutics Inc195,7040-195,704$2.00M$0—-$2.00M
Longboard Pharmaceuticals In31,5290-31,529$1.05M$0—-$1.05M
Neumora Therapeutics, Inc.(NMRA)432,9960-432,996$5.72M$0—-$5.72M
Phathom Pharmaceuticals, Inc.(PHAT)874,5900-874,590$15.81M$0—-$15.81M
Page 1 of 1
Saturn V Capital Management LP — 13F Holdings — Q4 2024 | TickerTrail